A carregar...
Total knee replacement with and without emicizumab: a unique comparison of perioperative management
Prophylaxis with emicizumab was used in a patient with severe hemophilia with an inhibitor who underwent knee surgery. Use of emicizumab during surgery led to less recombinant factor VIIa and less bleeding, in addition to cost savings, for this patient.
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7065482/ https://ncbi.nlm.nih.gov/pubmed/32126140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001060 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|